These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6290020)

  • 1. Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Cancer; 1982 Nov; 50(10):2024-7. PubMed ID: 6290020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP
    Obstet Gynecol; 1979 Dec; 54(6):725-8. PubMed ID: 229448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP; Jones MA; Marean AR; Bernstein MR
    Cancer; 1980 Feb; 45(3):423-6. PubMed ID: 6243507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1984 Oct; 19(2):173-81. PubMed ID: 6208089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms.
    Goldstein DP; Saracco P; Osathanondh R; Goldstein PR; Marean AR; Bernstein MR
    Obstet Gynecol; 1978 Jan; 51(1):93-6. PubMed ID: 201893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate with citrovorum factor in low-risk gestational trophoblastic tumor.
    Bolis G; Colombo N; Epis A; Mangili G; Vassena L; Vergadoro F; Belloni C
    Tumori; 1987 Jun; 73(3):309-13. PubMed ID: 3037744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000.
    McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES
    J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1986 Jan; 23(1):111-8. PubMed ID: 3002916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chemotherapies with methotrexate, VP-16 and actinomycin-D in low-risk gestational trophoblastic disease. Remission rates and drug toxicities.
    Matsui H; Iitsuka Y; Seki K; Sekiya S
    Gynecol Obstet Invest; 1998; 46(1):5-8. PubMed ID: 9692333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
    Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
    Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate with citrovorum factor rescue in gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1985 May; 152(1):59-62. PubMed ID: 2986458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmetastatic and low-risk metastatic gestational trophoblastic neoplasms.
    Goldstein DP; Berkowitz RS
    Semin Oncol; 1982 Jun; 9(2):191-7. PubMed ID: 6289462
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors.
    Berkowitz RS; Goldstein DP; Bernstein MR
    Gynecol Oncol; 1990 Jan; 36(1):56-9. PubMed ID: 2153091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
    Smith EB; Weed JC; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High risk malignant gestational trophoblastic disease: experience with triple chemotherapy (MAC) in Third World circumstances.
    du Toit JP
    Gynecol Oncol; 1989 Mar; 32(3):310-3. PubMed ID: 2465940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience.
    Garrett AP; Garner EO; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
    Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.